Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Can 99 percent of the people be more wrong than right, yep. If one doesn't like B.Damaj anyway, if you lost your money then it is lost. If you have significant skin in the game, then you are more interested in making money than second guessing morality and must believe you can make money despite B.Damaj . I think I can win here, but I recognize buyer beware applies.............
Ameritrade very well to buy DCTH !!!
(Healthywelth, it's quite amazing how profitability was projected at the end of 2017 and now you're saying profitability by the end of 2018. ) Like I said before our CEO - was too Optimistic last 2016-17 years . Its normal process growing company . When I open my Alkaline business, I was very optimistic too . got good $$$$$$ , but after was slowly , but after 2 years its UP with good $$$$$$$.
Its Ok , Honeycomd - we have time , we can wait . We will be rewarded if we are willing to give this company time to continue to expand and become profitable by end of 2018. p.s. nice waiting time.......................
INNV - have grown revenues from $800k in 2015 to about $5 million in 2016 and now all indications are they could be at $10 million in 2017. Along with that top line revenue growth, they are showing signs of good cost-controls and during each of the last four quarters, they have reduced their undistributed operating expenses like G&A and Sales. All this is narrowing the delta between profitability and non-profitability. If the recent trend from the past four (4) Quarters holds, we will see that we are ever so close to profitability at the NOI line. I am not hypothesizing here because we have factual information that Innovus is getting close to Profitability. Innovus' Net Income in Q3 2016 was -$4.4 million; in Q4 2016 it improved to -$3.4 million; in Q1 2017 it further improved to -$2.5 million and then in Q2 2017 it was -$1.1 million, and then in Q3 2017 it was little increase - $ 1.3 million. This trend is significant and tells me that the gradual increase in revenues and a concerted effort to control expenses is yielding positive results as show in the Income Statement. p.s.NET INCOME IN : Q3 2016 was -$4.4 million to DECREASE Q3 2017 - $1.3 million ( 73% !!!!! DECREASE ). WOW !!! not bad for growing company .
Think about . No need to pump....it will go up once the profitability is shown.
Love the continued reduction of expenses. I think the CEO is pretty determined to get to profitability and he is almost there. They missed EPS by 0.04 in Q3 2016 and missed by 0.01 this Q3. I am encouraged that they are increasing revenues YOY. Even if they don't get to the $10 million guidance for 2017, they are still going to double the $4.8 million 2016 total revenue with a lot less expenses, more cash on-hand, less debt.
(51M shares in play at 15 cents IS a cap - half would be exercised immediately between now and end of March. GLTA
) - its Ok , we have time ..........
(For the newbies - there are 51M warrants that's FIFTY ONE MILLION warrants that become in the money over 15 cents. Half, though, expire late March/early April 2018. ) Honeycomb - its Ok . We can wait , you was very optimistic few months ago, now you disappointed , upset ..... but its game - market .... you can not be patient , can not wait or not trust company just move out ...... but don't complain, its still real company with real product...
DSN drug store News . INNV - Article just out.......
http://www.drugstorenews.com/article/innovus-launches-low-cost-nasal-spray-allergy-relief-fluticare
https://www.amazon.com/gp/product/B00MXOVBO0/ref=abs_brd_tag_dp?smid=ATVPDKIKX0DER ONE PACK - PLUS SHIPPING FEE.
Nice try ....So what is your point Yevvy?
Point is - $30.00 & FREE Shipping....
https://www.amazon.com/FlutiCare-metered-Relief-allergy-allergens/dp/B0771X51Q2/ref=sr_1_1_a_it?ie=UTF8&qid=1511825564&sr=8-1&keywords=fluticare
For all - who try to do disinformation : Fluticare...$30.00 for(2 TWO - pk.) 120 measured doses.
Flonase/Flonaze....$19.00 for (1 ONE -pk. ) 120 measured doses. p.s. nice try , just more confirmed how you - LIES !!!!
https://www.amazon.com/FlutiCare-metered-Relief-allergy-allergens/dp/B0771X51Q2/ref=sr_1_1_a_it?ie=UTF8&qid=1511825564&sr=8-1&keywords=fluticare
https://www.amazon.com/gp/product/B00MXOVBO0/ref=abs_brd_tag_dp?smid=ATVPDKIKX0DER&th=1
p.s. nice try
Bob L.
Bob L.
3 hours ago
Just saw this on Amazon....
Fluticare...$30.00 for 120 measured doses.
Flonase/Flonaze....$19.00 for 120 measured doses)
(question Yevvy: what would you have said in November 2016 if I said this would be at .08-.09 as Fluticare was launching? Be honest. Tell me exactly what you would have said? ) First , Fluticare still not Word launching, even in US they just started . Second , price for me its fine , CEO was over optimistic , last year . Its gona take it time for growing company , two year ago they have nothing. p.s. Quastion is nobody care your opinion , nobody scare from your opinion . You - Home Alone ... but you get your coins ....
@Redsox1211 same, same , same - can you bring something new.... I repeat for you again , get your coin.... p.s. ( today's move looks like someone knows an S-4 is coming for additional shares that have already been dumped)....nice try......
Think about !!! All those customers who purchased 180 million units over the 10 years or ~ 18 million per year on average must have been pumpers too. I think people forget that Fluticare is the most sold product ever outselling other products by a wide margin. Nothing compares!!! I am sure that many of those customers will come back once they realize that product is back. Assuming only 10% of that 18 million average or 1.8m units x $13 brings us to $23.5m in revenue. This is conservative estimate given that annual number of units in year 10 was probably much higher than the average and company has publicly stated in their presentations that they expect 15% of folks who had prescriptions to come back.
(Nothing is confirmed) ??? You Home Alone here - CONFIRMED. BULLS IS HERE - and your days is numbered....
Don't be weak , before you was very optimistic. What's up now ? ..... but you was ONE think right . You said - after few weeks maybe month ... Bull is come in - in, and game will be changed !!! BULLS is HERE !!! Confirmed
WOW , just buy order pass 870K shares 0.096c. bid was 0.0912c. something cooking...Level 2 said
Dr. Damaj very Optimistic person ..... I do Alkaline water business , When I started , after few months got good profit , and put high numbers for next year , because its was look optimistic ... and number was less , this is process real grow company , be patient or get out ,this is my answer .........
p.s. Love the continued reduction of expenses. I think the CEO is pretty determined to get to profitability and he is almost there. They missed EPS by 0.04 in Q3 2016 and missed by 0.01 this Q3. I am encouraged that they are increasing revenues YOY. Even if they don't get to the $10 million guidance for 2017, they are still going to double the $4.8 million 2016 total revenue with a lot less expenses, more cash on-hand, less debt.
Nice Reminder - We will be rewarded if we are willing to give this company time to continue to expand and become profitable by end of 2018. p.s. please do your own DD......
No need to pump....it will go up once the profitability is shown.
Love the continued reduction of expenses. I think the CEO is pretty determined to get to profitability and he is almost there. They missed EPS by 0.04 in Q3 2016 and missed by 0.01 this Q3. I am encouraged that they are increasing revenues YOY. Even if they don't get to the $10 million guidance for 2017, they are still going to double the $4.8 million 2016 total revenue with a lot less expenses, more cash on-hand, less debt.
Nice Reminder -You will be rewarded if you are willing to give this company time to continue to expand and become profitable by end of 2018.
FlutiCare has a unique sales platform and they are potentially touching millions of people that Flonase and ClariSpray do not have. Just wait for the next allergy and hay fever season to start in March/April.
Also love the continued reduction of expenses. I think the CEO is pretty determined to get to profitability and he is almost there. They missed EPS by 0.04 in Q3 2016 and missed by 0.01 this Q3. I am encouraged that they are increasing revenues YOY. Even if they don't get to the $10 million guidance for 2017, they are still going to double the $4.8 million 2016 total revenue with a lot less expenses, more cash on-hand, less debt. I agree that meeting guidance is important but they don't have the institutional investors yet so I don't expect Wall Street to be punitive. Syd all time right ....................
Time 15:03 Level 2 - Ask price 0.089c.163217 shares , but buy two large order pass 0.0944c. 95K shares and 97K shares . nice dirty job MM.........think about weak hands...
You will be rewarded if you are willing to give this company time to continue to expand and become profitable by end of 2018.
FlutiCare has a unique sales platform and they are potentially touching millions of people that Flonase and ClariSpray do not have. Just wait for the next allergy and hay fever season to start in March/April.
Also love the continued reduction of expenses. I think the CEO is pretty determined to get to profitability and he is almost there. They missed EPS by 0.04 in Q3 2016 and missed by 0.01 this Q3. I am encouraged that they are increasing revenues YOY. Even if they don't get to the $10 million guidance for 2017, they are still going to double the $4.8 million 2016 total revenue with a lot less expenses, more cash on-hand, less debt. I agree that meeting guidance is important but they don't have the institutional investors yet so I don't expect Wall Street to be punitive.
For me the best predictor of success for a CEO (or anyone for that matter) is if she/he has GRIT. And this guy has "grit" and that tells me to hang with him despite all the noise by the day-traders and penny-pushers. This guy is not going down as some believe. This guy is determined to take INNV to higher ground. Syd all time right....
Redsox1211
2 minutes ago
Have to admit, this was a passionate, convincing conference call. Will add another, 20k shares tomorrow
If ER will be not good numbers, INNV will be report news about launched FRUTICARE tomorrow morning after ER , balancing price of shares . But now game look like changed .. p.s. its my opinion
CONGRATS to ALL LONG !!!!
Innovus Pharma Launches FlutiCare™ OTC Nasal Spray Allergy Relief in the U.S.
Business WireNovember 14, 2017
SAN DIEGO--(BUSINESS WIRE)--
Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter (“OTC”) medicine and consumer care products to improve men’s and women's health and respiratory diseases, today announced that it has officially launched FlutiCare™ OTC in the U.S. FlutiCare™ contains the most prescribed nasal steroid active pharmaceutical ingredient (“API”) and form for nasal allergy relief over the last 7 years. The Company is launching FlutiCare™ in over 10,000 independent pharmacies, direct and through Amerisource Bergen and McKesson, via its Beyond Human® extensive print media platform and through its extensive online channels and distributors, including its own website, Amazon, and Walmart online stores. As a second phase of its launch, Innovus Pharma will launch FlutiCare™ to large retail stores.
FlutiCare™ will be available OTC with the same prescription strength and same delivery method as Flonase®* and ClariSpray®*. The Company currently believes that FlutiCare™ will be the most affordable fluticasone propionate nasal spray on the market and is now available in one dose, a 30 Day (120 Sprays) treatment and is the only one providing an monthly autoship plan.
“We are very excited to launch FlutiCare™ OTC and provide all patients with allergy relief,” stated Dr. Bassam Damaj, President and Chief Executive Officer of Innovus Pharma. “FlutiCare™ traces its roots as the most prescribed Rx 24-hour nasal allergy spray API and form in the U.S. over the past 7 years by a factor of over 10 to 1,” he continued.
FlutiCare™ was approved by the U.S. Food and Drug Administration (“FDA”) for OTC availability through Innovus Pharma’s partner’s approved abbreviated new drug application (“ANDA”) No. 207957. FlutiCare™ allergy relief joins the growing Innovus Pharma product family, offering a burgeoning portfolio of non-prescription medicine and consumer care supplements to consumers.
Innovus Pharma Launches FlutiCare™ OTC Nasal Spray Allergy Relief in the U.S.
Business WireNovember 14, 2017
SAN DIEGO--(BUSINESS WIRE)--
Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter (“OTC”) medicine and consumer care products to improve men’s and women's health and respiratory diseases, today announced that it has officially launched FlutiCare™ OTC in the U.S. FlutiCare™ contains the most prescribed nasal steroid active pharmaceutical ingredient (“API”) and form for nasal allergy relief over the last 7 years. The Company is launching FlutiCare™ in over 10,000 independent pharmacies, direct and through Amerisource Bergen and McKesson, via its Beyond Human® extensive print media platform and through its extensive online channels and distributors, including its own website, Amazon, and Walmart online stores. As a second phase of its launch, Innovus Pharma will launch FlutiCare™ to large retail stores.
FlutiCare™ will be available OTC with the same prescription strength and same delivery method as Flonase®* and ClariSpray®*. The Company currently believes that FlutiCare™ will be the most affordable fluticasone propionate nasal spray on the market and is now available in one dose, a 30 Day (120 Sprays) treatment and is the only one providing an monthly autoship plan.
“We are very excited to launch FlutiCare™ OTC and provide all patients with allergy relief,” stated Dr. Bassam Damaj, President and Chief Executive Officer of Innovus Pharma. “FlutiCare™ traces its roots as the most prescribed Rx 24-hour nasal allergy spray API and form in the U.S. over the past 7 years by a factor of over 10 to 1,” he continued.
FlutiCare™ was approved by the U.S. Food and Drug Administration (“FDA”) for OTC availability through Innovus Pharma’s partner’s approved abbreviated new drug application (“ANDA”) No. 207957. FlutiCare™ allergy relief joins the growing Innovus Pharma product family, offering a burgeoning portfolio of non-prescription medicine and consumer care supplements to consumers.
FlutiCare™ becomes the Company’s second available allergy relief product along with AllerVarx™, a patented dietary supplement formulated to provide relief during the allergy season, already on the market
Syd from YB.
We continue to see a lot of frustration with this stock as I read some of the posts. While I can't judge others for feeling the resentment towards this company and its management, I can only share my position. I invested knowing full-well that this was a long-term proposition because many material milestones had to be met before we saw a rise in the SP. I believe the company is being transparent and managing its affairs in a professional manner. Above all, I really like how systematically they are executing their global strategies and acquiring/launching new products in the marketplace. They have grown revenues from $800k in 2015 to about $5 million in 2016 and now all indications are they could be at $10 million in 2017. Along with that top line revenue growth, they are showing signs of good cost-controls and during each of the last four quarters, they have reduced their undistributed operating expenses like G&A and Sales. All this is narrowing the delta between profitability and non-profitability. If the recent trend from the past four (4) Quarters holds, we will see that we are ever so close to profitability at the NOI line. I am not hypothesizing here because we have factual information that Innovus is getting close to Profitability. Innovus' Net Income in Q3 2016 was -$4.4 million; in Q4 2016 it improved to -$3.4 million; in Q1 2017 it further improved to -$2.5 million and then in Q2 2017 it was -$1.1 million. This trend is significant and tells me that the gradual increase in revenues and a concerted effort to control expenses is yielding positive results as show in the Income Statement.
In the final analysis, I invested in Innovus a year ago and knew this tiny company had potential for SP growth but that it would take time. Personally, for me, things are moving along in the right direction and I am confident that with the launch of the West-Ward FlutiCare later this month and the steady increase in revenues will eventually surpass the total expenses; and subsequently, we will see profitability and a positive EPS number. I believe when that happens; we will attract some institutional investors and broaden our base of retail investors. The market makers have had their fun in manipulating this stock but their days are numbered.
Thanks and for full-disclosure, the above is just one person's educated perspective; mine and I could be completely wrong.
Blessings!
Romans 4:18
,, Against all hope, Abraham in hope believed and so became the father of many nations,, ... In hope and honor of a good Q3 to the great glory of God!
AMEN .
,, DOGS BARKING , BUT CARAVAN GOES ,, ........
jtaylor68 - Don't feed him . Twistfreak-Redsox1211 - paid for each responded post back to him ( he confessed two month ago on Y.B. ) .
You spent your time in negativity here and YB ,.Sorry I forgot you get paid for each responded post back to you ( you confessed two month ago on Y.B. ) . We made good money Summer 2016 and will do again even more from INNV . p.s. So get your coin from me . .........................................Again ... How many post you sent last few weeks about INNV -72% ? ..... tik, tak, tik ,tak ..
I'm not Loser , like you. You spent your time in negativity here and YB ,.Sorry I forgot you get paid for each responded post back to you ( you confessed two month ago on Y.B. ) I have Nasdaq investment also . my average little over 0,10 cents . I made good money Summer 2016 and will do again even more from INNV . p.s. So get your coin from me . .........................................How many post you sent last few weeks about INNV -72% ? ..... tik, tak, tik ,tak ..
To All investors : jtaylor68 you absolutely Right - GOLD WORLDS : Naturally, if you absolutely can't make Peace with your investment, you should seriously contemplate selling your stake and retreat with your head held high, knowing you've learned an important investment lesson. Spend more time with quality DD instead of complaining and then oppose unfounded criticism with hard facts. Thanks jtaylor68 - Big Respect .
Nice Reminder !!! nice analysis but do your DD always..
Well, as a longtime holder of a lot of shares of this stock, I also wonder WHEN we'll see some some daylight here because we have been on the dark side for a while now. I also know that as demoralizing as that may be, better days are coming. There are several milestones on the horizon over the next six months so for those who just sold or are pretty dejected and have lost complete faith, I say please hang-in there for just six more months FlutiCare and we have the possibility of making $10+ million in top line revenue by 12/31/17 and becoming profitable. Based on the last earnings call and the Q1 income statement, operating expenses were leveling-off so that's why there is a small possibility INNV can be profitable in 2017 as well as cash-flow positive. Clearly, this is a slight modification from the previous guidance when the CEO believed that he needed about $15M in revenue to be profitable but the company now believes it can be profitable with even $10M in top line revenue. The profitability piece is a critical milestone because a positive year-over-year EPS number will have a significant impact on INNV getting noticed by the larger investment community.
Even if the company does $10M in 2017, I will take that 100% improvement over the previous year. The best business performers in the world generally do not DOUBLE their revenues from one year to the next. Even if FDA rejects FlutiCare, $10M is not a bad performance from the previous year's $4.8M or so.
With respect to the anticipated FDA approval for the original FlutiCare (fluticasone propionate), I still believe this nasal spray will be approved albeit much closer to the November 2017 deadline. My basis for this assumption is that fluticasone propionate is not a complex generic drug and we have several (same form) allergy rhinitis nasal sprays approved and already on the market.
INNV - Profitability is key here. There are many,many companies that waste billions in some drug that might or might not work. In this company we have products that are being sold, bringing in revenue with significant growth trajectory. I think that part of the problem is that people still view this as the pharma company which will continue to dilute to fund research and operations. Reality is that they are very close to being cash flow positive. Their cash burn rate was $400k last quarter. Once they become profitable life will be so much easier as they can invest cash that they generate back into the business without issuing new shares. In theory they could issue shares but that will be mostly to acquire new companies and/or products. My overall point is that people will wake up and realize not only the potential but also realize that this company has a very different business model vs other pharma companies.
Shawn - I'm here , very Healthy & Wealthy , and not complain , not cry ......... how bad everything . just watch ..... 274K shares average 0.103c. p.s. Nothing will happen until this time next year and after another 3000 - Cry posts (10/day) from ShawnP123. Wow. Batermere Right ...
I predicted all time - be Patient & Patient ....... New York not built one year .................... tik, tak , tik , tak ...
I liked this part ; ,, Similar to Flonase® and ClariSpray®, FlutiCare™ is approved for OTC by the FDA for “Allergy Symptom Relief” and is indicated to “Temporarily relieve these symptoms of hay fever or other upper respiratory allergies including,,
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c72952e6-bfe5-485b-8c62-787ff4179b62
I heard the same when I bought NOK $1.72c. & sold for $8.30c. , I heard the same when I bought AMD $1.91c. & sold $12.40c. everyone scrimping bankruptcy !!! INNV last summer the same ... we will see who is who very soon ...